Bisoprolol hemifumarate salt
SIGMA/B2185 - ≥98% (HPLC), solid
Synonym: 1-
CAS Number: 104344-23-2
Empirical Formula (Hill Notation): C18H31NO4 · .5C4H4O4
Molecular Weight: 383.48
MDL Number: MFCD00792743
Linear Formula: C18H31NO4 · .5C4H4O4
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | solid |
| InChI | 1S/2C18H31NO4.C4H4O4/c2*1 |
| InChI key | VMDFASMUILANOL-WXXKFALUSA |
| originator | Teva |
| Quality Level | 100 ![]() |
| SMILES string | OC(=O)C=CC(O)=O.CC(C)NC |
| solubility | DMSO: >20 mg/mL |
| Application: | Bisoprolol hemifumarate salt has been used as a β-adrenergic receptor (β-AR) antagonist in cardiac fibrosis mice model. |
| Biochem/physiol Actions: | Bisoprolol hemifumarate is useful in oral formulations due to its high bioavailability. It also shows long elimination half-life. |
| Biochem/physiol Actions: | Cardioselective β1-adrenoceptor antagonist. |
| Features and Benefits: | This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound was developed by Teva . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264 - P270 - P301 + P312 + P330 - P501 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |


